# French eCLIPs™ Efficacy and Safety Investigation

Study · id `cardio:ct-nct05330897` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05330897](<https://clinicaltrials.gov/study/NCT05330897>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT05330897

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 119 participants.

## Technical summary

Registry record NCT05330897. Allocation not applicable; no masking; primary purpose treatment. Start 2021-12-16 (actual); primary completion 2025-12-16 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 119 participants (planned count; ClinicalTrials.gov record NCT05330897, source copy `cardio:ctgov-nct05330897-2025-08-15`, retrieved 2026-11-18)
- Started: 2021-12-16 (actual) (ClinicalTrials.gov record NCT05330897, source copy `cardio:ctgov-nct05330897-2025-08-15`, retrieved 2026-11-18)
- Primary completion: 2025-12-16 (anticipated) (ClinicalTrials.gov record NCT05330897, source copy `cardio:ctgov-nct05330897-2025-08-15`, retrieved 2026-11-18)
- Completion: 2026-12-16 (anticipated) (ClinicalTrials.gov record NCT05330897, source copy `cardio:ctgov-nct05330897-2025-08-15`, retrieved 2026-11-18)
- Countries: France (ClinicalTrials.gov record NCT05330897, source copy `cardio:ctgov-nct05330897-2025-08-15`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05330897-2025-08-15`, retrieved 2026-11-18)

## The registry's words

- Brief title: French eCLIPs™ Efficacy and Safety Investigation
- Acronym: EESIS-Fr
- Condition: Intracranial Aneurysm
- Intervention (Procedure): Implantation of an eCLIPs™ device
- Intervention (Device): eCLIPs™ Electrolytic Bifurcation Systems
- Lead sponsor: Evasc Medical Systems Corp.
- Lead sponsor class: INDUSTRY
- Collaborator: European Cardiovascular Research Center
- Collaborator class: NETWORK

## Connected pages

- Registry condition terms include this condition: Brain aneurysm (intracranial aneurysm) (`cardio:intracranial-aneurysm`)
- Registry lists this organization as a collaborator: European Cardiovascular Research Center (`cardio:org-european-cardiovascular-research-center`)

## Provenance

Content hash: 90b4851869f107758d7cd0e8f65dd31ac28dc639f56eb7fb0c1788d6e2774003
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
